Latest Pharma Insights
Pipeline Watch: Seven Approvals And Nine Phase III Readouts
Pipeline Watch is a weekly snapshot of selected late-stage clinical trial events and approvals announced by pharmaceutical and biotech companies at medical and industry conferences, in financial and company presentations, and in company releases and statements.
Scrip - July 20, 2026
Pipeline Watch is a weekly snapshot of selected late-stage clinical trial events and approvals announced by pharmaceutical and biotech companies at medical and industry conferences, in financial and company presentations, and in company releases and statements.
Scrip - July 20, 2026
Caremark Settles FTC Case With Sweeping Drug-Pricing Reforms
CVS Caremark will overhaul rebates, patient cost-sharing, spread pricing and pharmacy reimbursement under an FTC settlement projected to deliver billions in savings.
Generics Bulletin - July 20, 2026
CVS Caremark will overhaul rebates, patient cost-sharing, spread pricing and pharmacy reimbursement under an FTC settlement projected to deliver billions in savings.
Generics Bulletin - July 20, 2026
No-Regrets Move: PwC Makes The Case For Building Consumer Health Innovation Around Wellness Goals
Consumers are managing their health continuously and across more product categories than ever. PwC's Anthony Bruce says this presents an opportunity for consumer health firms to orientate innovation around the goals, such as sleep, immunity and healthy aging, that consumers are already focused on.
HBW Insight - July 20, 2026
Consumers are managing their health continuously and across more product categories than ever. PwC's Anthony Bruce says this presents an opportunity for consumer health firms to orientate innovation around the goals, such as sleep, immunity and healthy aging, that consumers are already focused on.
HBW Insight - July 20, 2026
Hidden Cost Of Cancer Drug Shortages: Billions At Risk If Trial Protocols Unravel
Active US drug shortages rose for a third consecutive quarter, risking more clinical trial disruptions. In Vivo examines the likely fallout and explores solutions for cancer drug shortages as ASCO's chief medical officer warns of new drugs facing a potential threat of delays in approvals.
In Vivo - July 20, 2026
Active US drug shortages rose for a third consecutive quarter, risking more clinical trial disruptions. In Vivo examines the likely fallout and explores solutions for cancer drug shortages as ASCO's chief medical officer warns of new drugs facing a potential threat of delays in approvals.
In Vivo - July 20, 2026
UK Lauds Landmark Quarter For Biotech But Public Cash Drought Persists
The BIA says that while the UK's private investors "remain the powerhouse of European fundraising," the public markets are lagging behind the continent's peers, never mind the US.
Scrip - July 20, 2026
The BIA says that while the UK's private investors "remain the powerhouse of European fundraising," the public markets are lagging behind the continent's peers, never mind the US.
Scrip - July 20, 2026
HS Market Snapshot: A Heterogeneous Disease Still Waiting For Its Breakthrough
After a decade with just one biologic, hidradenitis suppurativa finally has a crowded pipeline, but doctors still can't reliably predict who any of these drugs will help.
Scrip - July 20, 2026
After a decade with just one biologic, hidradenitis suppurativa finally has a crowded pipeline, but doctors still can't reliably predict who any of these drugs will help.
Scrip - July 20, 2026
PolyPeptide Buy To Give Samsung Biologics Capacity In Surging Peptides Sector
Swiss firm's peptide expertise and sites to strengthen Korean giant's global multi-modality manufacturing capabilities.
Scrip - July 20, 2026
Swiss firm's peptide expertise and sites to strengthen Korean giant's global multi-modality manufacturing capabilities.
Scrip - July 20, 2026
Supplement Industry Plants Longtime Use Flag As US Looks At Expanding Peptide Bulk Drugs List
FDA Pharmacy Compounding Advisory Committee on July 23-24 will review numerous peptides for addition to its bulk list for compounding by state-licensed physicians and pharmacists under FD&C Act Section 503A.
HBW Insight - July 20, 2026
FDA Pharmacy Compounding Advisory Committee on July 23-24 will review numerous peptides for addition to its bulk list for compounding by state-licensed physicians and pharmacists under FD&C Act Section 503A.
HBW Insight - July 20, 2026
Pipeline Watch: Seven Approvals And Nine Phase III Readouts
Pipeline Watch is a weekly snapshot of selected late-stage clinical trial events and approvals announced by pharmaceutical and biotech companies at medical and industry conferences, in financial and company presentations, and in company releases and statements.
Scrip - July 20, 2026
Pipeline Watch is a weekly snapshot of selected late-stage clinical trial events and approvals announced by pharmaceutical and biotech companies at medical and industry conferences, in financial and company presentations, and in company releases and statements.
Scrip - July 20, 2026
UK Lauds Landmark Quarter For Biotech But Public Cash Drought Persists
The BIA says that while the UK's private investors "remain the powerhouse of European fundraising," the public markets are lagging behind the continent's peers, never mind the US.
Scrip - July 20, 2026
The BIA says that while the UK's private investors "remain the powerhouse of European fundraising," the public markets are lagging behind the continent's peers, never mind the US.
Scrip - July 20, 2026
HS Market Snapshot: A Heterogeneous Disease Still Waiting For Its Breakthrough
After a decade with just one biologic, hidradenitis suppurativa finally has a crowded pipeline, but doctors still can't reliably predict who any of these drugs will help.
Scrip - July 20, 2026
After a decade with just one biologic, hidradenitis suppurativa finally has a crowded pipeline, but doctors still can't reliably predict who any of these drugs will help.
Scrip - July 20, 2026
PolyPeptide Buy To Give Samsung Biologics Capacity In Surging Peptides Sector
Swiss firm's peptide expertise and sites to strengthen Korean giant's global multi-modality manufacturing capabilities.
Scrip - July 20, 2026
Swiss firm's peptide expertise and sites to strengthen Korean giant's global multi-modality manufacturing capabilities.
Scrip - July 20, 2026
Intuitive Surgical Posts Strong Q2 Revenues, Moves Into GI Endoscopy With FDA Submission
Intuitive Surgical reported strong second-quarter results with 19% revenue growth and 16% procedure growth. The medical robotics leader also disclosed an FDA 510(k) submission for a non-commercial flexible robotic endoscope for the gastrointestinal (GI) tract.
Medtech Insight - July 18, 2026
Intuitive Surgical reported strong second-quarter results with 19% revenue growth and 16% procedure growth. The medical robotics leader also disclosed an FDA 510(k) submission for a non-commercial flexible robotic endoscope for the gastrointestinal (GI) tract.
Medtech Insight - July 18, 2026
No-Regrets Move: PwC Makes The Case For Building Consumer Health Innovation Around Wellness Goals
Consumers are managing their health continuously and across more product categories than ever. PwC's Anthony Bruce says this presents an opportunity for consumer health firms to orientate innovation around the goals, such as sleep, immunity and healthy aging, that consumers are already focused on.
HBW Insight - July 20, 2026
Consumers are managing their health continuously and across more product categories than ever. PwC's Anthony Bruce says this presents an opportunity for consumer health firms to orientate innovation around the goals, such as sleep, immunity and healthy aging, that consumers are already focused on.
HBW Insight - July 20, 2026
Supplement Industry Plants Longtime Use Flag As US Looks At Expanding Peptide Bulk Drugs List
FDA Pharmacy Compounding Advisory Committee on July 23-24 will review numerous peptides for addition to its bulk list for compounding by state-licensed physicians and pharmacists under FD&C Act Section 503A.
HBW Insight - July 20, 2026
FDA Pharmacy Compounding Advisory Committee on July 23-24 will review numerous peptides for addition to its bulk list for compounding by state-licensed physicians and pharmacists under FD&C Act Section 503A.
HBW Insight - July 20, 2026
Caremark Settles FTC Case With Sweeping Drug-Pricing Reforms
CVS Caremark will overhaul rebates, patient cost-sharing, spread pricing and pharmacy reimbursement under an FTC settlement projected to deliver billions in savings.
Generics Bulletin - July 20, 2026
CVS Caremark will overhaul rebates, patient cost-sharing, spread pricing and pharmacy reimbursement under an FTC settlement projected to deliver billions in savings.
Generics Bulletin - July 20, 2026
Hidden Cost Of Cancer Drug Shortages: Billions At Risk If Trial Protocols Unravel
Active US drug shortages rose for a third consecutive quarter, risking more clinical trial disruptions. In Vivo examines the likely fallout and explores solutions for cancer drug shortages as ASCO's chief medical officer warns of new drugs facing a potential threat of delays in approvals.
In Vivo - July 20, 2026
Active US drug shortages rose for a third consecutive quarter, risking more clinical trial disruptions. In Vivo examines the likely fallout and explores solutions for cancer drug shortages as ASCO's chief medical officer warns of new drugs facing a potential threat of delays in approvals.
In Vivo - July 20, 2026